Lipid emulsion in non-local anesthetic toxicity meta-analysis. Exciting new research in the Journal of Medical Toxicology shows potential benefits for aluminum phosphide and organophosphate poisoning. @acmtmedtox @SpringerNature @lipidguy
link.springer.com/article/10…
Michael Fettiplace, MD PhD retweeted
Congratulations to Dr. Samer Narouze, named ASRA Pain Medicine’s 2026 John J. Bonica Award recipient! This prestigious honor recognizes his lifelong contributions to the development, teaching, and practice of pain medicine.
Learn more: ow.ly/zLRA50Zzwa2
Michael Fettiplace, MD PhD retweeted
Full paper: bit.ly/44dhnEd
Michael Fettiplace, MD PhD retweeted
🎁 A true Christmas surprise today! 🎄
The 2024 Annual Report of U.S. Poison Centers is here.
Fresh NPDS data, trends, and insights from >2.4 million exposures nationwide.
Happy holidays & happy reading!
PMID: 41432769
pubmed.ncbi.nlm.nih.gov/4143…
Michael Fettiplace, MD PhD retweeted
💉 Mixing local anesthetics for nerve blocks: faster onset or playing with fire? Some benefit in select cases—but risks and complex dosing make caution essential anesthesiologynews.com/a/-i4… #RegionalAnesthesia #PainManagement #Anesthesiology
Michael Fettiplace, MD PhD retweeted
ASRA Pain Medicine Newsletter also has the same guideline as RAPM on the use of AI @mfettiplace
🚨 Consensus guidelines on the use of A.I. 🚨
Balancing Speed and Integrity in the A.I. Era
VIEW INFOGRAPHIC HERE: doi.org/10.1136/rapm-2025-10…
READ GUIDELINE HERE: doi.org/10.1136/rapm-2025-10…
Michael Fettiplace, MD PhD retweeted
🚨 Consensus guidelines on the use of A.I. 🚨
Balancing Speed and Integrity in the A.I. Era
VIEW INFOGRAPHIC HERE: doi.org/10.1136/rapm-2025-10…
READ GUIDELINE HERE: doi.org/10.1136/rapm-2025-10…
Michael Fettiplace, MD PhD retweeted
A new case of lidocaine toxicity sparks renewed concern over tumescent anesthesia safety. Are current dosing practices and warnings enough? Explore the risks & calls for change 👇 anesthesiologynews.com/a/vzM… #PatientSafety #Anesthesiology #Lidocaine #MedicalAlert
Michael Fettiplace, MD PhD retweeted
🚨 Consensus guidelines on the use of A.I. 🚨
Balancing Speed and Integrity in the A.I. Era
VIEW INFOGRAPHIC HERE: doi.org/10.1136/rapm-2025-10…
READ GUIDELINE HERE: doi.org/10.1136/rapm-2025-10…
Michael Fettiplace, MD PhD retweeted
🚨 New data show lidocaine-linked deaths are *rising*—even as other local anesthetic fatalities fall. Experts urge stricter guidelines & awareness outside the OR. Read more 👉 anesthesiologynews.com/a/vjM… #PatientSafety #Anesthesia #Lidocaine #MedicalResearch
Michael Fettiplace, MD PhD retweeted
"[I]t will be critical to maintain a human in the loop even as we seek to incorporate the strengths of #AI-based review in our editorial process."
Read this Editorial from the editors and staff of JAMA and the JAMA Network journals.
ja.ma/4otK3kC
Michael Fettiplace, MD PhD retweeted
In kids, there’s much less in the way of hard 24 h limits (and a lot of different numbers floating around) so we most commonly think in terms of infusion rates. For ropivacaine, 0.3-0.5 mg/kg/h is generally well-tolerated in most kids…with adjustments for the very young: for 0-4 months use 0.2 mg/kg/h; for 5-12 months use 0.3 mg/kg/h. @mfettiplace , @BrittaniBungart and team did a really great paper on this recently—worth a read:
pubmed.ncbi.nlm.nih.gov/3742…
Michael Fettiplace, MD PhD retweeted
Replying to @klompenviking @amit_pawa
This is a great question—we often think about single doses but not cumulative. The drug label in the U.S. says “Experience to date indicates that a cumulative dose of up to 770 mg Naropin administered over 24 hours is well tolerated in
adults when used for postoperative pain management”. That’s what our team uses as a limit. So that means catheters infusing 0.2% can run a total of 16 ml/hr (our limit for 2 catheters is 8+8 for this reason). 16 ml x 2 mg/ml x 24 hr = 768 mg. That’s for adults…(1/2)
@mfettiplace @lipidguy @ASRA_Society @DaraEsra @ESRA_Society @BlockIt_Hot_Pod @EMARIANOMD @James_Kim_MD @RegionalAnaesUK
Michael Fettiplace, MD PhD retweeted
🤖 AI in Medical Publishing: Friend or Foe?
🔑 RAPM provides guidelines for responsible AI use in manuscripts—balancing innovation, transparency, and scientific integrity!
🔗 READ HERE -> doi.org/10.1136/rapm-2025-10…
Michael Fettiplace, MD PhD retweeted
💊 One vial. One error. One life.
Despite tech and AI, med errors still happen in the OR.
APSF is closing the gap between knowledge and implementation.
🎥 Why advocacy still matters after 40 years
apsf.org/article/apsfs-forty… #APSFNewsletter
Great summary 🥳 of our @RAPMOnline and @BJAJournals articles identifying a drop in local anesthetic poisoning 💊but an increase in #lidocaine 💉 deaths 💀 over the past 10 years. Links below ⏬
BJA article: bjanaesthesia.org/article/S0…
RAPM article: rapm.bmj.com/content/early/2…
@UIC_OVCR @uiccom @thisisUIC @lipidguy @hnixon147
Poisonings from local anesthetics dropped 50% over a decade.
But lidocaine poisonings rose more than 50% in just 4 years, @thisisUIC researchers found.
New studies suggest current safeguards may not be enough.
📰: today.uic.edu/lidocaine-pois…
Michael Fettiplace, MD PhD retweeted
🚨 Consensus guidelines with use of AI. 🚨
Balancing Speed and Integrity in the AI Era
READ HERE doi.org/10.1136/rapm-2025-10…
@mfettiplace @DrAnujBhatia @MdOrebaugh, @BrittaniBungart, @chrispcheng, @STHJournalClub, @Steve_Coppens, @VeselaKovachev2, @ChrisWuMD, & @EMARIANOMD
Concise infographic in @RAPMOnline about Delphi consensus recommendations for use of #AI 🤖 in writing ✍️ and publishing.
rapm.bmj.com/content/early/2…
Thanks to @Ryan_S_DSouzaMD and @sites_brian for all the assistance. Along with all Delphi members:
@mdorebaugh @dranujbhatia @drgofeld @rodneygabrielmd @hjlonsdale @brittanibungart @veselakovachev2 @chriswumd @emarianomd @drchadb @ElenaG_Bignami @franklindexter @gamcleod2 @lipidguy @jghardman26 @elboghdadly @marcvandevelde6 @cascellaus @rakesh6282 @rmaniker @pirracchior
Michael Fettiplace, MD PhD retweeted
#regionalanesthesia
Are you still mixing LA for upper extremity 💉?
Not once ….think twice or thrice before mixing of LA !
No benefits with cocktails 🍹 of LA !!
⚠️ ⛔️ 🛑
50 day 🆓 access to our systematic review !
🔥👉 sciencedirect.com/science/ar…
@rakesh6282 @adeebos @Ropivacaine
Michael Fettiplace, MD PhD retweeted
We have a new #regionalanesthesia fellowship position opening for January 2027 at @stanfordanes!
This is a chance to train with internationally-recognized expert faculty both at Stanford and @VAPaloAlto.
Please see flyer below for details and consider applying!





































